Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran

作者: Wei Zhou , Sönke Schwarting , Sergio Illanes , Arthur Liesz , Moritz Middelhoff

DOI: 10.1161/STROKEAHA.111.624650

关键词:

摘要: Background and Purpose—Dabigatran-etexilate (DE) recently has been approved for stroke prevention in atrial fibrillation. However, lack of effective antagonists represents a major concern the event intracerebral hemorrhage (ICH). The aims present study were to establish murine model ICH associated with dabigatran, test efficacy different hemostatic factors preventing hematoma growth. Methods—In C57BL/6 mice receiving DE (4.5 or 9.0 mg/kg), vivo vitro coagulation assays dabigatran plasma levels measured repeatedly. Thirty minutes after inducing by striatal collagenase injection, received an intravenous injection saline, prothrombin complex concentrate (PCC; 100 U/kg), fresh-frozen (200 μL), recombinant human factor VIIa (8.0 mg/kg). volume was quantified on brain cryosections 24 hours later. Results—DE substantially prolonged tail vein bleeding time ecarin clotting 4 corresponding ...

参考文章(26)
George J Broze, Zheng-Feng Yin, Nina Lasky, None, A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thrombosis and Haemostasis. ,vol. 85, pp. 747- 748 ,(2001) , 10.1055/S-0037-1615666
Sergio Illanes, Wei Zhou, Sabine Heiland, Zorn Markus, Roland Veltkamp, Kinetics of hematoma expansion in murine warfarin-associated intracerebral hemorrhage Brain Research. ,vol. 1320, pp. 135- 142 ,(2010) , 10.1016/J.BRAINRES.2010.01.015
David Garcia, Edward Libby, Mark A. Crowther, The new oral anticoagulants Blood. ,vol. 115, pp. 15- 20 ,(2010) , 10.1182/BLOOD-2009-09-241851
Christian Foerch, Ken Arai, Elizabeth Merrill Van Cott, Klaus van Leyen, Eng H Lo, Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin-associated intracerebral hemorrhage. Journal of Cerebral Blood Flow and Metabolism. ,vol. 29, pp. 1015- 1021 ,(2009) , 10.1038/JCBFM.2009.27
M. L. Flaherty, H. Tao, M. Haverbusch, P. Sekar, D. Kleindorfer, B. Kissela, P. Khatri, B. Stettler, O. Adeoye, C. J. Moomaw, J. P. Broderick, D. Woo, Warfarin use leads to larger intracerebral hematomas Neurology. ,vol. 71, pp. 1084- 1089 ,(2008) , 10.1212/01.WNL.0000326895.58992.27
L. Sjoblom, H.-G. Hardemark, A. Lindgren, B. Norrving, M. Fahlen, M. Samuelsson, L. Stigendal, D. Stockelberg, A. Taghavi, L. Wallrup, J. Wallvik, Management and Prognostic Features of Intracerebral Hemorrhage During Anticoagulant Therapy A Swedish Multicenter Study Stroke. ,vol. 32, pp. 2567- 2574 ,(2001) , 10.1161/HS1101.098523
H. L. HOLMBERG, B. LAURITZEN, M. TRANHOLM, M. EZBAN, Faster onset of effect and greater efficacy of NN1731 compared with rFVIIa, aPCC and FVIII in tail bleeding in hemophilic mice. Journal of Thrombosis and Haemostasis. ,vol. 7, pp. 1517- 1522 ,(2009) , 10.1111/J.1538-7836.2009.03532.X
Götz Nowak, The ecarin clotting time, a universal method to quantify direct thrombin inhibitors. Pathophysiology of Haemostasis and Thrombosis. ,vol. 33, pp. 173- 183 ,(2003) , 10.1159/000081505
David B Matchar, Alan Jacobson, Rowena Dolor, Robert Edson, Lauren Uyeda, Ciaran S Phibbs, Julia E Vertrees, Mei-Chiung Shih, Mark Holodniy, Philip Lavori, None, Effect of Home Testing of International Normalized Ratio on Clinical Events The New England Journal of Medicine. ,vol. 363, pp. 1608- 1620 ,(2010) , 10.1056/NEJMOA1002617